Streetbeat News

BINP

Bionoid Pharma Inc

Employees

Industry

Small Arms, Ordnance, and Ordnance Accessories Manufacturing

Open

0.27

Mkt cap

11M

Volume

15K

High

0.27

P/E Ratio

-0.20

52-wk high

1.00

Low

0.27

Div yield

N/A

52-wk low

0.05

Bionoid Pharma, Inc. has announced its growth strategy for 2025, focusing on acquiring revenue-positive e-commerce websites and integrating AI technology to expand in the health and wellness sector.

Portfolio Pulse from

January 14, 2025 | 12:45 pm

Bionoid Pharma, Inc. has reported over $100,000 in revenue after signing a Binding Letter of Intent with Your Supplement Supply Store Ltd., highlighting the strategic value and growth potential of the agreement.

Portfolio Pulse from

January 08, 2025 | 12:45 pm

Bionoid Pharma has introduced AI Maverick, a new sales automation platform, in a podcast. This platform aims to revolutionize the traditional sales process.

Portfolio Pulse from

November 27, 2024 | 12:45 pm

Bionoid Pharma, Inc. has launched a new subsidiary, Enhanced Supplements Ltd., to enhance its e-commerce capabilities, marking a strategic shift for the company.

Portfolio Pulse from

November 19, 2024 | 12:45 pm

Bionoid Pharma, Inc. has signed a Binding Letter of Intent to acquire the main e-commerce platform of Your Supplement Supply Store Ltd., EnhancedSupplements.net. This acquisition could expand Bionoid's market reach and enhance its online presence.

Portfolio Pulse from

November 12, 2024 | 12:45 pm

Bionoid Pharma, Inc. has appointed Olayinka Oyebola & Co. as its PCAOB external auditor, enhancing its commitment to transparency and regulatory standards in financial reporting.

Portfolio Pulse from

November 07, 2024 | 12:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.